Some choose off-label drug to treat macular degeneration

09/22/2006 | Miami Herald (free registration), The

While a new drug called Lucentis has been approved by the FDA to restore vision to people with macular degeneration, many doctors are using a similar drug, Avastin, off-label. That's because Avastin costs only about $50 per dose and Lucentis costs about $2,000 per injection.

View Full Article in:

Miami Herald (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Fremont, CA